Perrigo Q2 2025 Adj EPS $0.57 beats $0.53; net sales $1.06B down 0.9% YoY

PERRIGO Co plc

2025-Q2 EPS reported -$0.10 revenue$2,100,200,000

Reported EPS $0.00 vs $(0.77); Adj EPS $0.57 up 7.5% YoY on lower interest expense from reduced debt.
Net sales $1,056M down 0.9% YoY; organic net sales flat (-0.1%); CSCI organic +2.7%, CSCA organic -1.9%.
Reported operating income $45M vs $(27M) loss; Adj operating income $135M down 2.9% due to infant formula scrap and lower plant absorption.
Reaffirms FY2025 adj EPS target $2.90-$3.10; topline expected towards lower end of previous ranges.
Announced agreement to sell Dermacosmetics business, expected close Q1 2026; proceeds to strengthen balance sheet.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.